Results 161 to 170 of about 5,593,868 (306)

Stellar mass-loss in the dynamics of galaxies

open access: yes, 2014
Title: Stellar mass-loss in galactic dynamics Author: Miroslav Křížek Department: Astronomical Institute of the Charles University Supervisor: RNDr. Bruno Jungwiert, Ph.D., Astronomical Institute - Academy of Sciences of the Czech Republic, v.v.i.
Křížek, Miroslav
core  

BCG vaccination potentiates oxidative phosphorylation in neonatal myeloid‐derived suppressor cells

open access: yesFEBS Open Bio, EarlyView.
BCG vaccination enhances oxidative phosphorylation in neonatal MDSCs, impairing their immunosuppressive function. It upregulates electron transport chain genes and mitochondrial activity, increasing ATP and oxygen consumption. Pharmacological OXPHOS inhibition partially restores suppressive capacity, confirming causality.
Yingying Chen, Hui Li
wiley   +1 more source

Stellar winds and mass loss in A-type supergiants

open access: yes, 1997
We present the first systematic study on spectroscopical indicators of stellar winds and mass-loss in A-type supergiants. These stars are the coolest ones for which radiatively driven wind theory seems to be applicable. However, no systematic study has been carried out on a significant sample in order to test the correctness of this theory.
openaire   +1 more source

Probing the Mass-Loss History of VY CMa

open access: yes, 2008
Mass loss plays a dominant role in the evolution of low mass stars while they are on the Asymptotic Giant Branch (AGB). Recent studies have hinted towards the importance of time variability of the mass-loss rates of such objects.
Decin, L.   +5 more
core  

Chronobiology of Cancer: How Aging Fuels Oncogenesis at the Molecular Level

open access: yesAging and Cancer, EarlyView.
This graphical abstract illustrates the key biological pathways linking aging with cancer development and progression. In the upper left, cumulative exposure to ultraviolet radiation, toxins, and reactive oxygen species (ROS) causes DNA damage and genomic instability, whereas age‐related decline in repair mechanisms, such as ATM/ATR, BER, and NER ...
Anu Singh, Aroonima Misra, Sufian Zaheer
wiley   +1 more source

Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants. ABSTRACT Objective Return of disease activity is expected when patients discontinue disease‐modifying therapy (DMT) for multiple sclerosis (MS). Some MS DMTs are associated with higher‐than‐expected disease activity (rebound) after discontinuation.
Ralf Gold   +12 more
wiley   +1 more source

Evolution Of Rotating Low Mass Stars With Angular-Momentum Loss

open access: yes, 1991
The evolutionary behavior of rotating low mass stars has been investigated with angular momentum loss by the magnetic stellar wind through the pre-main sequence and on the zero age main sequence phases.
KIZILOGLU, N
core  

Relationship Between Neurologic Symptoms and Signs and FMR1 Genotype in Premutation Carriers

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background and Objectives Fragile X‐associated Tremor/Ataxia Syndrome (FXTAS) is the most severe late‐onset condition caused by a premutation in the FMR1 gene, characterized by expanded CGG triplet repeats of 55–200. Clinical presentations of FXTAS, including gait ataxia, kinetic tremor, cognitive decline, and rare Parkinsonism, are linked to ...
Flora Tassone   +8 more
wiley   +1 more source

Conference summary: Mass loss from stellar clusters

open access: yes, 2007
This conference dealt with the mass loss from stars and from stellar clusters. In this summary of the cluster section of the conference, I highlight some of the results on the formation and the fundamental properties of star clusters (Sect. 2), the early
Gieles, M
core  

Risk of Non‐Arteritic Anterior Ischemic Optic Neuropathy in Idiopathic Intracranial Hypertension Patients Treated with GLP‐1 Receptor Agonists

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Introduction Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) have demonstrated significant weight‐reducing effects and may offer benefits in idiopathic intracranial hypertension (IIH); however, recent concerns about the risk of non‐arteritic anterior ischemic optic neuropathy (NAION) have emerged.
Faisal A. Al‐Harbi   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy